Alzheimer’s drug development roundup – July 2024
From exciting data on cell therapy and monoclonal antibodies, through…
From exciting data on cell therapy and monoclonal antibodies, through to new regulatory developments, this article summarises some of the key developments within the Alzheimer’s therapeutic landscape over July.